Systematic overview of hepatitis C infection in the Middle East and North Africa

Table 4 Hepatitis C antibody incidence and/or seroconversion risk rate relative to the total sample size, and evidence gap mapping, Middle East and North Africa

Country	Systematic review	Literature search period	Number of studies identified	Number of subjects	Population type	Estimation time period	HCV incidence rate (per 1000 person-year)	Loss of follow-up	HCV sero-conversion risk (%)	Duration of follow-up
Algeria	Fadlalla, 2015[52]	1980-Unknown	0	0
Libya	Fadlalla, 2015[52]	1980-Unknown	0	0
Morocco	Fadlalla, 2015[52]	1980-Unknown	1	303	Hemodialysis patients	2003-2004	97	-	-	-
Tunisia	Fadlalla, 2015[52]	1980-Unknown	1	276	Hemodialysis patients	2000-2002	28	-	-	-
Djibouti	Chaabna, 2016[27]	Inception-2015	0	0
Sudan	Chaabna, 2016[27]	Inception-2015	0	0
Egypt	Hussein, 2016[48]	Inception-Unknown	-	-	-	-	6.9	-	-	-
	Mohamoud, 2013[61]	Inception-Unknown	2	2852	Children of villages with high HCV prevalence	2000-2006	2.7	-	-	-
	Mohamoud, 2013[61]	Inception-Unknown	3	10318	General population	1997-2003	0.8-6.8	-	-	-
	Mohamoud, 2013[61]	Inception-Unknown	1	2177	Pregnant women	1997-2006	5.2	-	-	-
	Sievert, 2011[50]	Unknown	-	-	Pregnant women	-	5.2	-	-	-
Pakistan	Sievert, 2011[50]	Unknown	0	0